# Continuous Glucose Monitoring for Glucose and Weight Management in Prediabetes and Non-severe Type 2 Diabetes: A Prospective Community-based (Workplace) Cohort Study

Study · id `cardio:ct-nct06542627` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06542627](<https://clinicaltrials.gov/study/NCT06542627>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06542627

Browse, organ or system: Metabolism  
Browse, condition area: Risk and prevention; Diabetes and metabolic disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 420 participants.

## Technical summary

Registry record NCT06542627. Allocation not applicable; no masking; primary purpose treatment. Start 2023-05-22 (actual); primary completion 2025-12-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 420 participants (planned count; ClinicalTrials.gov record NCT06542627, source copy `cardio:ctgov-nct06542627-2024-08-07`, retrieved 2026-10-26)
- Started: 2023-05-22 (actual) (ClinicalTrials.gov record NCT06542627, source copy `cardio:ctgov-nct06542627-2024-08-07`, retrieved 2026-10-26)
- Primary completion: 2025-12-31 (anticipated) (ClinicalTrials.gov record NCT06542627, source copy `cardio:ctgov-nct06542627-2024-08-07`, retrieved 2026-10-26)
- Completion: 2025-12-31 (anticipated) (ClinicalTrials.gov record NCT06542627, source copy `cardio:ctgov-nct06542627-2024-08-07`, retrieved 2026-10-26)
- Countries: South Korea (ClinicalTrials.gov record NCT06542627, source copy `cardio:ctgov-nct06542627-2024-08-07`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06542627-2024-08-07`, retrieved 2026-10-26)

## The registry's words

- Brief title: Continuous Glucose Monitoring for Glucose and Weight Management in Prediabetes and Non-severe Type 2 Diabetes: A Prospective Community-based (Workplace) Cohort Study
- Condition: PreDiabetes
- Condition: Diabetes Mellitus, Type 2
- Intervention (Device): Freestyle Libre
- Lead sponsor: Kangbuk Samsung Hospital
- Lead sponsor class: OTHER
- Collaborator: Samsung Electronics
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Prediabetes (`cardio:prediabetes`)
- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)
- Registry lists this organization as the lead sponsor: Kangbuk Samsung Hospital (`cardio:org-kangbuk-samsung-hospital`)

## Provenance

Content hash: d757766f29d05f0f8a61a82c0bd29adcc64b59bc23926c3fb2290e856022ccad
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
